Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/08/072210
CTRI/2024/08/072210
Not yet recruiting
未知

Follow up study of the patients enrolled in a hospital based multi center registry for common medical retinal diseases - NI

BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCI0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCI
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCI

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with these aforementioned stages of diabetic retinopathy, 2\. Central and branch retinal vein occlusions
  • •3\. Age related macular degeneration or CNVM who are already enrolled in the registry entitled A hospital\-based multicentre registry for common medical retinal diseases ?
  • •4\. Patients who were already enrolled in the registry entitled A hospital\-based multicentre registry for common medical retinal diseases.

Exclusion Criteria

  • •Patients who were not enrolled in the registry entitled A hospital\-based multicentre registry for common medical retinal diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Observational study of hospitalized patients with heart failure at the Japanese Red Cross Wakayama Medical Center
JPRN-UMIN000053982Japanese Red Cross Wakayama Medical Center1,000
Completed
Not Applicable
Prospective observational study of hospitalization associated disability in the elderly patients living with advanced non-small cell lung cancer.non-small cell lung cancer
JPRN-UMIN000013171Shizuoka Cancer Center33
Recruiting
Not Applicable
Observational Study to follow up patients enrolled in FIRST-Dx trial.Chemotherapy-naive adult patients with advanced cancer (GI, Lung, Breast, GYN, Melanoma)
JPRN-jRCT1050220041Muto Manabu180
Active, not recruiting
Phase 1
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)Acquired thrombotic thrombocytopenic purpura (TTP)MedDRA version: 20.0Level: PTClassification code 10043648Term: Thrombotic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2016-001503-23-ATAblynx NV104
Active, not recruiting
Phase 1
Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)
EUCTR2016-001503-23-GBAblynx NV104